STAQ Pharma, Inc.: Drug Recall

Recall #D-0633-2022 · 02/03/2022

Class I: Dangerous

Recall Details

Recall Number: D-0633-2022
Classification: Class I
Product Type: Drug
Recalling Firm: STAQ Pharma, Inc.
Status: Terminated
Date Initiated: 02/03/2022
Location: Denver, CO, United States
Voluntary/Mandated: Voluntary: Firm initiated
Product Quantity: 905 Syringes

Reason for Recall

Labeling: Label Mix up; A limited number of syringes containing HYDROmorphone HCl PF were incorrectly labeled as Morphine Sulfate PF with lot number 21104221A

Product Description

HYDROmorphone HCl PF 10 mg/50 mL (0.2mg/mL) in NaCl, 50 mL in 50 mL Single Dose Syringe, Rx only, STAQ Pharma, Inc., Denver, CO 80239, NDC: 73177-0104-05.

Distribution Pattern

CO, OH, and TX.

Other Recalls by STAQ Pharma, Inc.

Class III: Low Risk 10/09/2025

Labeling: Incorrect or Missing Lot and/or Exp Date
Class III: Low Risk 10/09/2025

Labeling: Incorrect or Missing Lot and/or Exp Date
Class III: Low Risk 10/09/2025

Labeling: Incorrect or Missing Lot and/or Exp Date
Class II: Risk 11/29/2023

STAQ Pharma Inc. received consumer complaints related to leaking bags and other potential bag concerns. Upon investigation, they determine the source of the issue was with the bag manufacturer who released bags Lot # 134142-001A which had failed internal QC tests for leaks.
Class I: Dangerous 02/03/2022

Labeling: Label Mix up; A limited number of syringes containing HYDROmorphone HCl PF were incorrectly labeled as Morphine Sulfate PF with lot number 21104221A

View all recalls by STAQ Pharma, Inc. →

Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.